Editing
Upper Urinary Tract Urothelial Cancer
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Risk-Stratification of Localized UTUC == === AUA === * [https://pubmed.ncbi.nlm.nih.gov/37096584/ '''2023 AUA Guidelines on Upper Tract Urothelial Carcinoma'''] ** '''<span style="color:#ff0000">Categorized as high- vs. low-risk</span>''' of disease progression and pathologic stage β₯T2 disease ***'''<span style="color:#ff0000">Based on biopsy grade</span>''' ****Association of high grade tumor on ureteroscopic biopsy with high-stage disease (β₯pT2) on final pathology *****Positive predictive value: 60% *****Negative predictive value:77% ***'''<span style="color:#ff0000">Sub-stratified into favorable vs. unfavorable (see [https://www.auajournals.org/doi/10.1097/JU.0000000000003480 Table 4]), based on (4):</span>''' ***#'''<span style="color:#ff0000">Cytology</span>''' ***#'''<span style="color:#ff0000">Radiographic appearance</span>''' ***#*'''<span style="color:#ff0000">Multifocality</span>''' ***#*'''<span style="color:#ff0000">Size</span>''' ***#*'''<span style="color:#ff0000">Invasive features</span>''' ***#**Heterogenous texture on enhanced and even unenhanced CT imaging has been associated with invasive disease ***#*'''<span style="color:#ff0000">Obstruction of the urinary tract</span>''' ***#*'''<span style="color:#ff0000">Locoregional progression such as suspicious lymphadenopathy</span>''' ***#*'''<span style="color:#ff0000">Presence of metastatic disease</span>''' ***#'''<span style="color:#ff0000">Endoscopic appearance</span>''' ***#*'''<span style="color:#ff0000">Appearance (sessile, papillary, flat/villous)</span>''' ***#*'''<span style="color:#ff0000">Multifocality</span>''' ***#*'''<span style="color:#ff0000">Size</span>''' ***#**Tumors β₯ 1.5 cm in size are associated with a > 80% risk of invasive disease ***#**Measurement in the pre-surgical setting is not standardized and has not been shown to be independent of other more easily determined clinically identified features such as multifocality, invasion and obstruction. ***#'''<span style="color:#ff0000">Lower tract involvement</span>''' ***#*'''Pan-urothelial disease as indicated by history of prior cystectomy, concomitant or metachronous lower tract urothelial cancer or contralateral UTUC diagnosis'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information